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Abstract
Osteosarcoma (OS) is an aggressive bone tumor with complex abnormal karyotypes and a highly unstable ge-
nome, exhibiting both numerical- and structural-chromosomal instability (N- and S-CIN). Chromosomal rearrange-
ments and genomic imbalances affecting 8q24 are frequent in OS. RECQL4 gene maps to this cytoband and
encodes a putative helicase involved in the fidelity of DNA replication and repair. This protective genomic function
of the protein is relevant because often patients with Rothmund-Thomson syndrome have constitutional mutations
of RECQL4 and carry a very high risk of developing OS. To determine the relative level of expression of RECQL4
in OS, 18 sporadic tumors were studied by reverse transcription–polymerase chain reaction. All tumors over-
expressed RECQL4 in comparison to control osteoblasts, and fluorescence in situ hybridization analysis of tumor
DNA showed that expression levels were strongly copy number–dependent. Relative N- and S-CIN levels were
determined by classifying copy number transitions within array comparative genomic hybridization profiles and
by enumerating the frequency of break-apart fluorescence in situ hybridization within 8q24 using region-specific
and control probes. Although there was no evidence that disruption of 8q24 in OS led to an elevated expression of
RECQL4, there was a marked association between increased overall levels of S-CIN, determined by copy number
transition frequency and higher levels of RECQL4.
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Introduction
Osteosarcoma (OS) is the most common primary bone malignancy
and is characterized by complex chromosomal abnormalities that vary
widely from cell to cell. These tumors exhibit a high degree of an-
euploidy, gene amplification, and multiple unbalanced chromosomal
rearrangements. A combined approach of molecular cytogenetics
techniques [comparative genomic hybridization (CGH), spectral karyo-
typing, or multicolor banding] together with classic G-banded cyto-
genetics analysis of OS tumors describe complex karyotypes with
multiple numerical and structural chromosomal aberrations. Collectively,
these studies [1–12] have highlighted the unique and highly unstable
karyotype of OS.
Two distinct processes governing genome stability may be dis-
rupted in cancer cells: those that affect numerical segregation and
ploidy of chromosomes and those that affect the fidelity of DNA
replication/repair and lead to structural chromosome aberrations (re-
viewed in [13]). The complexity of the OS genome likely arises as
a consequence of chromosomal instability (CIN), generated by both
Address all correspondence to: Jeremy A. Squire, PhD, Translational Laboratory Re-
search, NCIC Clinical Trials Group, Department of Pathology and Molecular Medicine,
Richardson Labs, 88 Stuart St, Queen’s University, Kingston, Ontario, Canada K7L 3N6.
E-mail: squirej@queensu.ca
1This research is supported by the Canadian Cancer Society 016215. G.M. is the
recipient of the Helena Lam award.
2This article refers to supplementary materials, which are designated by Tables W1
and W2 and are available online at www.neoplasia.com.
Received 29 October 2008; Revised 21 December 2008; Accepted 22 December 2008
Copyright © 2009 Neoplasia Press, Inc. All rights reserved 1522-8002/09/$25.00
DOI 10.1593/neo.81384
www.neoplasia.com
Volume 11 Number 3 March 2009 pp. 260–268 260
numerical and structural chromosome abnormalities. Numerical pat-
terns of chromosomal aberration have been referred to as N-CIN,
whereas CIN that leads to elevated levels of structural change has
been termed S-CIN. The development of high-resolution array com-
parative genomic hybridization (aCGH) methods provides an oppor-
tunity to analyze genomic complexity at both the N-CIN and S-CIN
level using whole-genome imbalance plots. In this approach, the re-
spective distributions of copy number alteration present within the
entire aCGH profile can be used to determine the relative contribu-
tions of S-CIN [as defined by copy number transitions (CNTs) [14],
within each chromosome] or N-CIN (as defined by chromosomal
imbalance affecting an entire chromosome) to the overall complexity
of the OS genome in a given tumor. Previously [15], we have used
aCGH analysis of OS to map chromosomal regions recurrently sub-
ject to genomic changes such as gene amplification. In the current
article, we further interrogate aCGH profiles to measure levels of
S-CIN and N-CIN in OS in the context of genomic and molecular
changes of cytoband 8q24.
Some chromosomal regions are more frequently involved in ge-
nomic aberrations in OS, namely, 1p35-p36, 6p12-p21, 8q23-q24,
17p11-p12, and 19p13 [4] (reviewed in [16]). The 8q24 region is of
particular interest to OS because a number of genes both directly and
indirectly implicated in OS oncogenesis map to this region. The MYC
oncogene at 8q24 is highly amplified in a subset of OS [17,18], is
overexpressed more frequently in relapsed and metastatic OS [19],
and is often amplified in a wide variety of carcinomas [20]. RECQL4
maps to this same cytoband and the gene encodes a putative helicase
involved in the fidelity of DNA replication, and this protective genomic
function of the protein is provocative because patients with constitu-
tional mutations of RECQL4 have Rothmund-Thomson syndrome
(RTS) and carry a very high risk of developing an OS [21]. Approxi-
mately two-thirds of patients with a clinical diagnosis of RTS will
have RECQL4 mutations. The other one third likely represents genetic
heterogeneity and have mutations in another gene(s). The RTS patients
with RECQL4 mutations have a much higher risk of developing OS
compared with the RTS patients without RECQL4 mutations [22].
Moreover, the 8q24 cytoband is now of particular interest to cancer
biologists because recent genome-wide association studies have identi-
fied multiple neighboring regions within a 600-kb segment of chromo-
some 8q24 that harbors variants associated with predisposition to
prostate, colon, and bladder cancers [23–25]. The most likely candidate
gene within the 8q24 region that could contribute directly to the CIN
phenotype of OS is the RECQL4 gene, which encodes a helicase mem-
ber of the RecQ family [26].
In this study, we address the hypothesis that deregulation ofRECQL4
expression, caused by the 8q24 rearrangements, could underlie the
high rate of CIN observed in OS. Complex genomic alterations and
amplifications at 8q24 were of particular interest because the affected
regions are relatively small; they have been found to be aberrant in
multiple OS samples and they are located in a region of the human
genome strongly implicated in tumorigenesis and DNA repair. If
genomic alterations occur near the RECQL4 region, it is conceivable
that such changes lead to deregulation of the locus, and this may
compromise its repair and DNA maintenance functions, with conse-
quences for the entire genome’s integrity [26–30]. In the present study,
we used 18 OS tumor samples to investigate whether RECQL4
gene expression levels were linked to the extent and type of CIN
(N-CIN and S-CIN) throughout the OS genome and specifically
at 8q24.
Materials and Methods
Patient Tumors
The collection of frozen tissue specimens (n = 18), archival formalin-
fixed, paraffin-embedded OS sections (n = 12), and clinicopathologic
data was obtained and handled in accordance with the Hospital for
Sick Children Research Ethics guideline (Toronto, Canada). The OS
specimens and corresponding paraffin-embedded specimens consisted
of resected or biopsy tumor tissue obtained at diagnosis. Hematoxylin
and eosin–stained sample sections were subjected to standard histo-
pathologic evaluation to determine the tumor content and the patho-
logic grade according to the World Health Organization [31]. All
samples presented a tumor content higher than 90%. The clinical
and histologic features of presented OS cohort are detailed in Table 1.
Cell Culture
The RTS primary fibroblasts were obtained from the Corriell
Institute for Medical Research (AG18371; Camden, NJ) [32]. These
fibroblasts do not express RECQL4 because of an 11-bp intronic dele-
tion, which disrupts the splicing and compromises its expression
[32,33]. They were cultured in alpha–minimum essential medium
(Invitrogen, Burlington, Ontario, Canada) supplemented with 10%
heat-inactivated fetal calf serum (Invitrogen). Osteoblasts were ob-
tained from PromoCell (Heidelberg, Germany) and cultured in osteo-
blast culture medium (PromoCell).
RNA Extraction and Semiquantitative Reverse
Transcription–Polymerase Chain Reaction
The mRNA level of RECQL4 was examined by semiquantitative
reverse transcription–polymerase chain reaction (RT-PCR), using the
housekeeping gene PBGD as a calibration control. Total RNA from
snap-frozen OS tumors (18 samples) and from cultured cells (RTS
fibroblasts and osteoblasts) were isolated using the TRIzol Reagent
(Invitrogen). The RNA quality was assessed by BioAnalyzer RNA
600 Nano Kit (Agilent Technologies, Palo Alto, CA). Total RNA
from kidney and testis (Ambion, Foster City, CA) were used as posi-
tive control detection for low and high RECQL4 expressions, respec-
tively [34]. Total RNA from RTS fibroblasts were used as negative
control [33,35]. Coamplification of RECQL4 and PBGD genes
Table 1. Clinical Data of the 18 OSs.
No. Sex Age (years) Localization Sample Subtype Grade
OS1 F 9 Tibia Biopsy Osteoblastic High
OS2 M 14 Femur Lesion Osteoblastic High
OS3 M 13 Femur Biopsy Osteoblastic Intermediate
OS4 M 7 Humerus Biopsy Poorly differentiated High
OS5 F 12 Femur Biopsy Poorly differentiated High
OS6 M 14 Femur Biopsy Osteoblastic High
OS7 M 7 Femur Biopsy Osteoblastic High
OS8 M 13 Femur Resection Osteoblastic High
OS9 F 13 Humerus Biopsy Osteoblastic High
OS10 M 8 Tibia Resection Osteoblastic High
OS11 M 13 Femur Biopsy Osteoblastic High
OS12 M 17 Lung Resection Osteoblastic High
OS13 M 9 Leg Biopsy Poorly differentiated High
OS14 F 12 Femur Biopsy Osteoblastic Intermediate
OS15 F 14 Femur Biopsy Osteoblastic High
OS16 F 17 Tibia Resection Osteoblastic High
OS17 M 15 Tibia Resection Osteoblastic High
OS18 M 15 Femur Biopsy Poorly differentiated High
F indicates female; M , male.
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was performed on 150 ng of total RNA by applying the one-step
RT-PCR method (Superscript One-Step RT-PCR III; Invitrogen)
according to the manufacturer’s instructions. RECQL4 forward (5′-
CTCATCTAAGGCATCCACCC-3′) and reverse (5′-CTGTGA-
CATCGCTGTAACCA-3′) primers were designed to amplify a 188-bp
fragment (Accession Number NM_004260). PBGD primers were de-
signed to amplify a 127-bp fragment [36]. Primers for RECQL4 and
PBGD were combined as follows: 0.2 μMof each forward and reverse
RECQL4 primers and 0.15 μM of each forward and reverse PBGD
primers. The reverse transcription and amplification conditions were
performed using the MJ Research PTC200 thermocycler and con-
sisted of an initial reverse transcription reaction at 57°C for 30 min-
utes, followed by denaturation (2 minutes at 94°C) and 30 cycles
of amplification (94°C for 30 seconds; 57°C for 30 seconds; 68°C
for 30 seconds). The final elongation reaction was performed at 68°C
for 10 minutes. Genomic DNA contamination in every sample was
excluded by omitting the reverse transcriptase in the RT-PCR.
The measurement and quantification of the 188-bp (RECQL4) and
127-bp (PBGD) coamplified fragments were performed using the
DNA 1000 LabChip Kit (Agilent 2100 Bioanalyzer; Agilent Tech-
nologies) and the 2100 Expert Software (Agilent Technologies), re-
spectively. PBGD was used for calibration, and the mRNA fold
change of RECQL4 in OS cohort was compared with the normal osteo-
blasts. The SD from triplicate RT-PCR experiments was calculated for
each sample.
Genome-wide Analysis of Chromosomal Instability
Ten OS samples for which sufficient total DNA could be extracted
were hybridized against Human Genome CGH 44k microarrays
(Agilent Technologies), spanning the entire human genome at a me-
dian resolution of 75 kb as described previously [15]. These aCGH
data files have also been used to map the distribution of recurrently
deleted and amplified regions in OS [15] and they are deposited in
National Center for Biotechnology Information’s Gene Expression
Omnibus (GEO) Web site (http://www.ncbi.nlm.nih.gov/geo/) and
are accessible through the GEO Series accession number GSE9654.
For each tumor, the normalized data were run through the Circular
Binary Segmentation (CBS) algorithm [37], with a threshold of 0.5
(CGH Analytics, 3.5.14; Agilent Technologies). The CBS algorithm
provides a list of aberrations (imbalanced genomic region with a
unique abnormal CGH ratio), each determined by two CNTs, as de-
fined by Ferreira et al. [14]. The distribution along the chromosome
of these CNTs for each aberration was used to determine the respec-
tive contribution of N-CIN and S-CIN (Table W1). Briefly, an aber-
ration with the starting and ending CNTs positioned within an arm of
a chromosome was considered to be caused by copy number change
arising from an unbalanced structural alteration and was scored as
S-CIN. An aberration, which CNTs were positioned in telomeric or
centromeric regions, was considered to result from copy number
change affecting an entire chromosome or chromosome arm and was
scored as N-CIN. All the aberrations were classified as N- or S-CIN–
related and scored for each of the 10 OS tumors studied by aCGH.
The aberrations on X and Y chromosomes were excluded from the anal-
ysis to eliminate the sex mismatching bias.
Fluorescence In Situ Hybridization
Dual-color fluorescence in situ hybridization (FISH) method was
applied to the 5-μm thick archival formalin-fixed, paraffin-embedded
tissue sections. Bacterial artificial chromosome (BAC) genomic clone
RP11-349C2 was identified in the Resources for Molecular Cyto-
genetics database (www.biologia.uniba.it) by its location at the
RECQL4 locus (chr8:145,707,623-145,713,976, UCSC genome
browser, www.genome.ucsc.edu, version March 2006). The BAC
clone was obtained from the Centre for Applied Genomics (Toronto,
Ontario, Canada). The presence of the RECQL4 sequence and the
correct chromosome location of the BAC clone were verified by PCR
and by hybridization to metaphase spreads from normal peripheral
lymphocytes, respectively. The BAC probe was labeled either with
ULYSIS-Alexa-594 or with ULYSIS-Oregon-green-488 (Molecular
Probes, Invitrogen) and was combined with the alpha satellite centro-
meric probe of chromosome 8, cen(8) (CEP 8 SpectrumGreen; Abbott
Molecular, Des Plaines, IL) or with a commercial MYC-containing
probe (LSI C-MYC-SpectrumOrange; Abbott Molecular), respectively.
Dual-color FISH was performed according to standard procedures
[38]. Either RECQL4 and cen(8) or RECQL4 and MYC were evalu-
ated by spot visualization and enumeration for each probe in a range
from 50 to 100 nonoverlapped, intact interphase nuclei per tumor tis-
sue using a Zeiss Imager.Z1 microscope equipped with a digital camera
AxioCam MRm and AxioVision 4.3 capturing software (Carl Zeiss
Canada, Ltd., Toronto, Canada). If fluorescent signals could not be
seen in at least 80% of cells, the result was considered to be noninter-
pretable (6/12). The most represented pattern of signal was recorded
for the probe combinations mentioned above. The establishment of a
cutoff value of >10% of tumor nuclei for the different probes used and
for all signal patterns was defined considering the truncation artifacts,
aneusomy, nuclear size, and chromatin condensation [39]. The relative
gene copy number of RECQL4 was calculated by adding the number of
RECQL4 signals to the RECQL4/cen(8) ratio. This calculation allowed
to enhance the distinction between a ratio of 1 with two copies of each
probe (2:2), and a ratio of 1 with three to five copies of each probe
(3:3, 4:4, and 5:5). The pattern of signals (contiguous vs scattered) for
the dual-color FISH experiment using RECQL4 and MYC probes was
evaluated nucleus by nucleus to document the S-CIN of the 8q24 re-
gion. The observation of scattered signals was interpreted as the mani-
festation of S-CIN.
Chromosome copy number analysis was performed using centro-
meric enumeration probes for cen(3) (CEP 3 SpectrumRed), cen(7)
(CEP 7 SpectrumGreen), and cen(17) (CEP 17 SpectrumAqua;
Abbott Molecular). Sequential three-color FISH method was applied
to the paraffin-embedded tissue sections according to the manufac-
turer’s instructions. Chromosome enumeration was determined by
scoring the number of signals for cen(3), cen(7), and cen(17) in 200
nonoverlapped intact interphase nuclei (10 of the 12 samples reached
these criteria). The estimation of the overall ploidy of each sample is
described case by case in the supplementary material (Table W2).
Briefly, adapted from Rossi et al. [40], the OS cohort was classified
by ploidy FISH as follows: 1) diploid, >50% of cells showing two
signals for all probes; 2) near-triploid, >20% of cells showing three
signals for at least two probes; 3) near-tetraploid, >20% of cells show-
ing four signal for at least two probes; 4) polyploidy, >50% of cells
showing more than five signals for at least one probe [40].
Results
RECQL4 Expression Levels in OS Determined
by RT-PCR Analysis
To establish the expression level of RECQL4 in OS samples, we
performed semiquantitative RT-PCR using total RNA extracted from
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patient tumors. We demonstrated that RECQL4 was overexpressed in
all the tested tumors compared with normal osteoblasts. The mean
expression levels observed for all 18 OS tumors was ∼13-fold higher
than osteoblasts (range, ×3 to ×30; Figure 1). In keeping with the
published literature, RECQL4 could not be detected in RNA-derived
RTS fibroblasts [33,35]. OS1 exhibited the lowest level of RECQL4
expression, which was comparable to the low expression level ob-
served in normal kidney tissue. In contrast, OS18 was characterized
by an expression twice higher than that of the normal testis sample,
which has been shown to be one of the most RECQL4-rich tissues
[34]. We conclude that the expression level of RECQL4 is deregu-
lated in OS.
Association of RECQL4 Expression and Genome-wide
Chromosomal Instability Levels
To determine whether there was a relationship between expression
levels of RECQL4 and overall levels of CIN, we analyzed aCGH pro-
files to distinguish between N-CIN and S-CIN using 10 of the 18
tumors. Analysis of CNT distributions within each chromosome and
the pattern of overall chromosomal imbalance present in each aCGH
profile provided an objective overview of the variation in N-CIN
and S-CIN levels that characterized each of the 10 OS analyzed
(Table W1 and Figure 2). The mean number of N-CIN changes
was 10.4 (SD, 5) for the study group, with no apparent relationship
between the levels of RECQL4 expression and N-CIN (Figure 2A).
In contrast, there was a clear trend showing an increase in S-CIN
with higher expression levels of RECQL4. For example, OS18 had
the highest expression level and exhibited >300 S-CIN aberrations
and OS1 showed the lowest-expressing tumor for RECQL4 and
had only 11 S-CIN aberrations. The mean number of S-CIN for
the study group was 74.1 (SD, 95; Figure 2B). Collectively, these data
indicate that elevated RECQL4 expression is associated with a greater
incidence of CNTs and concomitant elevation in S-CIN frequency.
We were not able to demonstrate any relationship between N-CIN
levels and varying levels of gene expression of RECQL4.
Influence of RECQL4 Gene Copy Number on
Its Expression in OS
The variation of the RECQL4 expression in OS could be the result
of genomic copy number changes of the locus at 8q24. Dual-color
interphase FISH analysis, using the RECQL4 and the cen(8) probes,
was therefore performed on formalin-fixed, paraffin-embedded tissue
derived from 12 OS tumors. As illustrated in Figure 3, A–D, and sum-
marized in Table 2, we show that the increase of RECQL4 expression
followed the genomic status of the RECQL4 gene. To determine copy
number changes, cohybridization of RECQL4 and cen(8) probes and
systematic analysis of the dual-color patterns allowed us to quantify
numerical chromosome 8 abnormalities. OS samples with the lowest
expression of RECQL4 (such as OS1 and OS4) have two normal chro-
mosome 8s each bearing two copies of RECQL4 and cen(8) (Fig-
ure 3A). In OS2, four cen(8)s were present with only two copies of
the RECQL4 gene, suggesting that a tetrasomy of chromosome 8 also
involved RECQL4 loss (Figure 3B). OS5, OS7, and OS9 had a higher
expression of RECQL4 (below the mean value) and three to five copies
for each RECQL4 and cen(8) probes (Figure 3, C andD). This pattern
could be interpreted as an acquisition of extra copies of an intact chro-
mosome 8. Lastly, OS samples with the highest RECQL4 expression,
(above the mean) all exhibited a copy number gain of RECQL4, which
was observed as nine RECQL4 signals with four cen(8) for OS15 (Fig-
ure 3E ) or six RECQL4 signals for two cen(8) as in OS13 (Figure 3F ).
Collectively, these findings indicate that of RECQL4 gene expression is
largely copy number–dependent (Table 2).
Influence of Structural Alterations of Cytoband 8q24 on
RECQL4 Expression in OS
We used dual-color interphase FISH to study S-CIN levels within
8q24.21 (MYC probe) and 8q24.4 (RECQL4 probe) cytobands. Be-
cause both probes are closely linked within 8q24, paired two-color
signals within nuclei can be used to determine whether disruption
of the cytoband has taken place. In four OS tumors (OS1, OS4,
OS5, and OS7), there was no evidence of disruption between
MYC and the RECQL4 probes within nuclei (Table 3 and Figure 3,
G and H ). For six OS tumors, disruption of 8q24 was apparent. In
OS13 (Figure 3I ), six copies of 8q24 were apparent, but the red and
green signals were no longer paired, indicative of structural rearrange-
ment between the MYC and RECQL4 loci. In OS15 (Figure 3J ), we
observed the most complex signal pattern in the series; no pairing
of green and red signals was apparent, and there was also evidence
of numerical change. Thus, a range of structural aberrations affect-
ing 8q24, varying from simple to complex, was apparent within this
Figure 1. RECQL4 is overexpressed in OS and is associated with
S-CIN. The histogram is showing the fold change of RECQL4mRNA
compared with normal osteoblasts (NO) measured by semiquanti-
tative RT-PCR. Rothmund-Thomson fibroblasts (RTS) and normal
tissues (kidney and testis) were used as negative and positive
controls, respectively. Each value is the result of three independent
experiments. The SD is shown above each bar. The dashed line
represents the mean value calculated from OS sample data. The
lower panel part describes the chromosomal 8 instability (CIN) in
the context of overall ploidy for 10 samples for which material
was available for FISH studies. The absence of N-CIN or S-CIN is
shown as (−). Identification of S-CIN or N-CIN is shown as (+).
The overall ploidy statuswas established according to the FISHdata
using cen(3), cen(7), and cen(17). OS tumors that are showing an
RECQL4 expression value close ormore than themean are showing
S-CIN, whereas the ones less than the mean do not. The N-CIN and
S-CIN are independent, and a high level of RECQL4 expression is
associated with the appearance of S-CIN on the 8q24 region.
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series of OS tumors. The varying levels of both N-CIN and S-CIN in
the 10 OS as determined by FISH analyses of 8q24 with probes are
detailed in Table 3. OS1 and OS4 did not exhibit numerical or 8q24
structural aberrations. OS5 and OS7 were both characterized by
N-CIN only, whereas OS12 and OS13 had S-CIN only. The largest
Figure 2. Association between RECQL4 expression levels and
varying N-CIN and S-CIN frequencies. (A) Differing frequencies of
N-CIN (y-axis) as determined by analyzing imbalance profiles of
whole chromosomes or entire arms for the 10 OS tumors (x-axis)
after aCGH analysis. (B) Differing frequencies of S-CIN (y-axis) as
determined by analyzing CNT distributions across each genomic
profile derived from the ten OS tumors (x-axis) after aCGH analysis.
The OS samples are ordered from left to right according to their
RECQL4 expression level (lowest to highest) and are represented
as a triangle in which the adjacent side represents the highest
RECQL4 expression level.
Figure 3. (A–F) RECQL4/cen(8) dual-color interphase FISH experi-
ment on OS tumors samples’ fixed sections. RECQL4 probe is
shown in red, whereas the cen(8) is in green. OS samples exhibited
a normal pattern [OS1 (A)], a loss [OS2 (B)], an abnormal pattern as-
sociated with a 1:1 ratio [OS7 (C) and OS9 (D)], or a gain of RECQL4
[OS15 (E) and OS13 (F)]. (G–J) Structural CIN of the 8q24 cytoband.
Dual-color interphase FISHwas done on fixed tissue sections using
theMYC probe (red) located on 8q24.21 and the RP11-349C2 probe
(green) located on 8q24.3. The signal pattern of contiguous red and
green signals on OS7 (G) and OS1 (H) identifies these samples as
no S-CIN for the 8q24 cytoband. In contrast, for OS13 (I) and OS15
(J), the red and green signals are scattered all around the nuclei,
characterizing these two samples as S-CIN for the 8q24 region.
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group of tumors, OS9, OS11, OS15, and OS18 had more complex
FISH patterns, with both N- and S-CIN occurring together at 8q24.
We then compared RECQL4 expression findings in tumors with N- or
S-CIN at 8q24 to determine whether expression levels were associated
with numerical or structural alterations of this region of chromo-
some 8. OS tumors with RECQL4 expression values that were close
or higher than the mean value (13.5) across the 18 OS samples had
S-CIN for the 8q24 region. This relationship held regardless of the
N-CIN level or ploidy for chromosome 8 (Figure 1). Moreover, OS
with the highest S-CIN levels determined by aCGH (shown above)
also had the highest S-CIN level with the 8q24 cytoband region. These
findings do not indicate that disruption of 8q24 leads to elevated ex-
pression of RECQL4 per se; rather, elevated RECQL4 is strongly asso-
ciated with a greater overall frequency of S-CIN.
Discussion
Previous studies of the RECQL4 gene have shown a strong associa-
tion between constitutional mutations of the locus and predisposi-
tion to OS with 32% of RTS patient developing OS [22]. Moreover,
fibroblasts and lymphocytes from RTS exhibit both N- and S-CIN
[41–45]. Sequence analyses of RECQL4 in a large series of sporadic
OS tumors failed to detect mutations in a significant proportion (only
3 samples of 71 had mutation/deletion) [46], but no study to date has
determined the RECQL4 genomic status or analyzed expression levels
in the context of CIN in OS.
The biologic function of the RECQL4 protein is poorly under-
stood. The extensive studies of RTS, BLM and WRN, and other
members of the RecQ helicase family, have not provided conclusive
information concerning the specific and diverse functions of the
RECQL4 protein. It is clear that for all three syndromes, germ line
mutation of a specific RecQ helicase gene is associated with prema-
ture aging, CIN, and predisposition to diverse types of cancer [47].
However, there are important clinical and biologic differences be-
tween these genes. For example, conserved areas of the RECQL4
and BLM helicase motif do not have functional equivalence in vitro
[27]. Each syndrome has distinct clinical features, and the associated
cancer risk involves a different spectrum of tumors [48–50]. More-
over, the prominent class of CIN observed in the lymphocytes or
fibroblasts of each syndrome varies, with RTS being characterized
by chromatid breaks and isochromosomes, BLM by triradial and
quadriradial figures, and WRN by multiple clones with distinctive
balance translocations [50–52]. Interestingly, recent characterization
of the overexpression of the RecQ helicases has shown it to be linked
with the deregulation of the Rb pathway and the RAS activation.
These data provide additional support to our supposition that there
is an association between oncogenesis and RecQ helicases’ over-
expression [53]. In the proposed model, RecQ helicases’ overexpression
Table 2. RECQL4 Relative Gene Copy Number and Expression Analysis.
No. RECQL4 Copy Number (Genomic Status) cen(8) Copy Number RECQL4 Relative Copy Number* RECQL4 Expression (Fold Change)†
OS1 2 (N) 2 3 3
OS2 2 (L) 4 2.5 4
OS4 2 (N) 2 3 6
OS5 4 (AN) 4 5 6
OS7 3 (AN) 3 4 8
OS9 5 (AN) 5 6 10
OS11 6 (G) 4 7.5 14
OS12 3 (G) 2 4.5 14
OS13 6 (G) 2 9 15
OS15 8 (G) 4 10 22
OS16 9 (G) 2 13.5 23
OS18 5 (G) 3 6.6 30
AN indicates aneusomy; G, gain; L, loss; N, normal.
*RECQL4 relative number is calculated as described in the Materials and Methods section.
†Expression of RECQL4 is normalized against the PBGD housekeeping gene expression, and shown as a fold change compared with the expression level measured in normal osteoblasts.
Table 3. Relative Levels of Numerical and Structural Chromosomal Instability in 10 OSs.
No. Numerical Aberration Structural Aberration of Chromosome 8 Type of CIN for Chromosome 8
Overall Ploidy* cen(8) RECQL4 Copy Number MYC Copy Number Pattern of RECQL4 and MYC FISH Signals
OS1 Diploid 2 2 3 Not rearranged —
OS4 Diploid 2 2 2 Not rearranged —
OS5 Near-triploid 4 4 4 Not rearranged N-CIN
OS7 Near-triploid 3 3 3 Not rearranged N-CIN
OS9 Polyploid (>5n) 5 4 4 Scattered S- and N-CIN
OS11 Diploid 4 6 4 Scattered S- and N-CIN
OS12 Near-tetraploid 2 3 2 Scattered S-CIN
OS13 Diploid 2 6 6 Scattered S-CIN
OS15 Near-tetraploid 4 8 5 Scattered S- and N-CIN
OS18 Near-triploid 3 5 3 Scattered S- and N-CIN
CIN indicates chromosomal instability; N-CIN, numerical chromosomal instability; S-CIN, structural chromosomal instability.
*The overall ploidy has been estimated by the enumeration of cen(3), cen(7), and cen(17) (Table W2) as described in the Materials and Methods section.
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would promote and facilitate the DNA synthesis and telomere main-
tenance, processes that are mandatory for any transformed cells. How-
ever, similar to the different effects of the WRN, BLM, or RECQL4
mutations, the regulation of the RecQ helicase seems to be specific for
each of the member [53]. In the last few years, several groups identi-
fied a more specific function for the RECQL4 helicase, specially its
involvement in the early steps of replication fork machinery [27–
30]. In an animal model, Sangrithi et al. [28] showed that the Xenopus
laevi RECQL4 homolog is associated with chromatin during replica-
tion initiation and makes the origin of replication accessible to the rep-
lication factors. This function acts on the initiation and the unraveling of
single-stranded DNA at the origin of replication. An altered expression
of RECQL4 could disturb the processes governing the duration and
extent of single-strand DNA exposure. Therefore, these single-stranded
DNA regions would be the targets of DNA fragility and breaks. This
abnormal single configuration of DNA is likely to promote interchro-
mosome exchanges in a pseudo homolog recombination way. Because
RECQL4 is activated by single-strandDNA and it promotes annealing
of single-strand DNA to its complementary sequence, an excess of
RECQL4 could force unmatched DNA annealing sequence, whereas
a lack of RECQL4 could impair proper reannealing of separated
strands of DNA [27]. Thus, the deregulation of RECQL4 could have
profound consequences on overall genomic integrity and CIN in terms
of structural complexity and heterogeneity.
By mapping the distribution of regions of imbalance and, in particu-
lar, determining the location of CNTs (Table W1) within each chro-
mosome, it is possible to evaluate the relative contributions of N-CIN
and S-CIN to destabilizing theOS genome. In this study, we have found
that elevated RECQL4 expression is associated with a greater overall fre-
quency of structural chromosomal change, but there was no obvious re-
lationship between expression and N-CIN levels (Figure 2). Moreover,
S-CIN changes were also apparent when FISH was used to determine
the frequency of structural alteration at cytoband 8q24. It is possible that
the elevated levels of RECQL4 would keep the DNA in a prolonged
single stranded vulnerable stage, and promote the S-CIN. A result of
this deregulation would be the perpetual initiation of S-CIN, leading
to a polyclonal population of cells within one tumor. Indeed, OS tumor
can exhibit highly polyclonal population where the most represented
clone could account for only 30% of the cell [2–4].
Overexpression of RECQL4 has also been reported in other sarco-
mas (leiomyosarcoma, liposarcoma, and synovial sarcoma) and in
some carcinomas (breast, colon, cervix, and laryngeal squamous
cells), and its elevated expression has been correlated with metastasis
or a later stage of disease [54–58]. Of these tumors, none have been
studied systematically to determine whether S-CIN levels are elevated.
However, in liposarcoma, the presence of a supernumerary giant
chromosomes that varies structurally from cell to cell suggests ongo-
ing instability [59]. These observations would give RECQL4 a strong
impact in oncogenesis in general. In the present study, the MYC
amplicon (8q24.21) seems to be independent of from the RECQL4
locus (8q24.3). The study by Mai and Mushinski [60] suggests that
amplification and deregulation of MYC lead to instability character-
ized by gene amplification rather than by elevated frequencies of
structural chromosomal rearrangement. This would be consistent
with our finding: we observed a disruption of the 8q24 cytoband
rather than an over–replication/amplification pattern (Figure 3, I
and J ), as one would expect as a result of an MYC-driven S-CIN in
a given tumor. Furthermore, MYC is a multifunctional protein that
acts on cell cycle, apoptosis, and cellular transformation through its
transcription factor activity [20]. Conversely, RECQL4 seems to be
more involved in specific DNAmetabolism. We therefore suggest that
the imbalances of theMYC oncogene and RECQL4 are two indepen-
dent processes of oncogenesis.
In this study, we have investigated the relationship between S-CIN/
N-CIN in OS and the RNA expression levels of RECQL4. We find
that whereas ploidy changes and elevated N-CIN is common in OS,
the more structurally abnormal tumors have higher levels of RECQL4.
OS with the highest S-CIN levels determined by aCGH also had the
highest S-CIN level with the 8q24 cytoband region. We found no evi-
dence that disruption of 8q24 led to an elevated expression of RECQL4;
rather, elevated RECQL4 is strongly associated with a greater overall
frequency of S-CIN that characterizes the OS genome.
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Table W1. Identification of N-CIN and S-CIN in Study Group of 10 OS.
Chromosome Cytoband Aberration Location ↔ CIN Type
N-CIN S-CIN
chr1 p36.33 Telomere
p12 -p36.32 Arm
p11.2 Centromere
q21.1 Centromere
q21.2-q43 Arm
q44 Telomere
chr2 p25.3 Telomere
p12-p25.2 Arm
p11.2 Centromere
q11.2 Centromere
q12.1-q37.2 Arm
q37.3 Telomere
chr3 p26.3 Telomere
p11.2-p26.2 Arm
p11.1 Centromere
q11.2 Centromere
q12.1-q28 Arm
q29 Telomere
chr4 p16.3 Telomere
p13-q16.2 Arm
p12 Centromere
q11 Centromere
q12-q35.1 Arm
q35.2 Telomere
chr5 p15.33 Telomere
p12-p15.32 Arm
p11 Centromere
q11.1 Centromere
q11.2-q35.3 Arm
q35.3 Telomere
chr6 p25.3 Telomere
p12.1-p25.2 Arm
p11.2 Centromere
q11.1 Centromere
q11.2-q26 Arm
q27 Telomere
chr7 p22.3 Telomere
p11.2-p22.2 Arm
p11.1 Centromere
q11.21 Centromere
q11.22-q35.2 Arm
q36.3 Telomere
chr8 p23.3 Telomere
p11.22-p23.2 Arm
p11.21 Centromere
q11.1 Centromere
q11.21-q24.2 Arm
q24.3 Telomere
chr9 p24.3 Telomere
p13.2-p24.2 Arm
p13.1 Centromere
p12 Centromere
q12 Centromere
q13 Centromere
q21.11-q34.2 Arm
q34.3 Telomere
chr10 p15.3 Telomere
p11.22-q15.2 Arm
p11.21 Centromere
q11.21 Centromere
q11.22-q26.2 Arm
q26.3 Telomere
chr11 p15.5 Telomere
p11.2-p15.4 Arm
p11.12 Centromere
q11 Centromere
q12.1-q24.3 Arm
q25 Telomere
Table W1. (continued )
Chromosome Cytoband Aberration Location ↔ CIN Type
N-CIN S-CIN
chr12 p13.33 Telomere
p11.21-p13.32 Arm
p11.1 Centromere
q12 Centromere
q13.11-q24.32 Arm
q24.33 Telomere
chr13 q12.11 Centromere
q12.12-q33.33 Arm
q34 Telomere
chr14 q11.1 Centromere
q11.2-q32.32 Arm
q32.33 Telomere
chr15 q11.2 Centromere
q12-q26.2 Arm
q26.3 Telomere
chr16 p13.3 Telomere
p12.1-p13.2 Arm
p11.2 Centromere
q12.1 Centromere
q12.2-q24.2 Arm
q24.3 Telomere
chr17 p13.3 Telomere
p12-13,2 Arm
p11.2 Centromere
q11.1 Centromere
q11.2-q25.2 Arm
q25.3 Telomere
chr18 p11.32 Telomere
p11.22-p11.31 Arm
p11.21 Centromere
q11.2 Centromere
q12.1-q22.3 Arm
q23 Telomere
chr19 P13.3 Telomere
p13.11-p13.2 Arm
p12 Centromere
q12 Centromere
q13.11-q13.42 Arm
q13.43 Telomere
chr20 p13 Telomere
p11.22-p12.3 Arm
p11.21 Centromere
q11.21 Centromere
q11.22-q13.32 Arm
q13.33 Telomere
chr21 p11.1 Centromere
q11.2 Centromere
q21.1-q22.2 Arm
q22.3 Telomere
chr22 q11.1 Centromere
q11.21-q13.32 Arm
q13.33 Telomere
The position of genomic imbalance from all 10 OS is shown by cytoband location. Structural aberrations leading to S-CIN imbalance is mapped by black boxes and N-CIN imbalance is indicated by
gray boxes.
Table W2. Estimation of the Overall Ploidy of 10 Samples.
OS cen(3),* n (%) cen(7),* n (%) cen(17),* n (%) Overall Ploidy Status†
OS1 2 (60%) 2 (70%) 2 (70%) Diploid
3 (15%) 3 (>10%) 3 (15%)
4 (<10%)
OS4 1 (30%) 2 (60%) 2 (60%) Diploid
2 (60%) 3 (20%) 3 (20%)
OS5 2 (70%) 2 (50%) 2 (40%) Near-triploid
3 (>10%) 3 (20%) 3 (40%)
4 (>10%)
OS7 2 2 (50%) 2 (35%) Near-triploid
3 (20%) 3 (40%)
4 (>10%) 4 (>10%)
OS9 2 2 (60%) 2 (>10%) Polyploid (>5 n)
3 (>10%) 3 (20%)
>5 (60%)
OS11 2 2 (60%) 2 (70%) Diploid
3 (15%) 3 (>10%)
OS12 2 (80%) 2 (30%) 3 (>10%) Near-tetraploid
3 (>10%) 3 (30%) 4 (20%)
4 (20%) 5 (20%)
5 (>10%) >5 (30%)
OS13 2 2 (50%) ND Diploid
4 (15%)
OS15 1 (30%) 2 (50%) 2 (40%) Near-tetraploid
2 (60%) 3 (20%) 3 (30%)
4 (20%) 4 (20%)
OS18 2 (70%) 2 (53%) 2 (60%) Near-triploid
3 (>10%) 3 (27%) 3 (20%)
4 (>10%)
*For each sample, 200 nuclei were scored, and a population of cell was recorded if it was repre-
sented by more than 10% of the cells.
†Overall ploidy criteria are established according to Ventura et al. [39], with modification described
in the Materials and Methods section.
